NCT03561896: Hypofractionated Brain Radiationcavity

NCT03561896
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER++, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Radiation therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: 
Exclusions: Patient with history of previous brain irradiation
https://ClinicalTrials.gov/show/NCT03561896

Comments are closed.

Up ↑